Treace Medical Concepts TMCI
NASDAQ TMCI
$4.46 -0.10 (-2.19%)
As of: Aug 20, 2026 · 3:59 PM EDT

Treace Medical Concepts (TMCI) Preferred Shares (2020 - 2021)

Treace Medical Concepts' (TMCI) quarterly Preferred Shares came in at $7.9 million in Q1 2021, little changed on a QoQ basis from $7.9 million in Q4 2020.

Treace Medical Concepts (TMCI) Preferred Shares (2020 - 2021) Analysis & Trends

Treace Medical Concepts (TMCI) has 2 years of Preferred Shares data on file, last reported at $7.9 million in Q1 2021.

  • Quarterly Preferred Shares changed N/A year-over-year to $7.9 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $7.9 million (changed N/A YoY) and the FY2020 annual result came in at $7.9 million, changed N/A from the prior year.
  • Preferred Shares was little changed at $7.9 million in Q1 2021, from $7.9 million in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $7.9 million in Q4 2020 to a low of $7.9 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Treace Medical Concepts 290.12 Mn 244.50 Mn 35.61 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 7.94 Mn
Dec 31, 2020 7.94 Mn